Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 7 Solid Tumor 1 Ovarian Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Breast Neoplasm Female 1 Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed 1

Interventions

Fluorouracil 80 Oxaliplatin 72 Leucovorin 66 Irinotecan 60 Capecitabine 58 Bevacizumab 57 Cetuximab 43 Folfox protocol 22 Drug Therapy 22 Neoadjuvant Therapy 19 HMPL-013 17 Colonoscopy 17 regorafenib 15 apatinib 11 Panitumumab 11 Chemotherapy, Adjuvant 11 trifluridine tipiracil drug combination 10 XELOX 10 Laparoscopy 10 IFL protocol 10 sintilimab 9 raltitrexed 9 Radiotherapy 9 Blood Specimen Collection 9 Surveys and Questionnaires 8 Surgical Procedures, Operative 8 tislelizumab 7 pembrolizumab 7 Endoscopic Mucosal Resection 7 Aspirin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colorectal Neoplasms × dalpiciclib × Clear all

NCT05480280 2023-02-28

FIND

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡